Sonnet Biotherapeutics Holdings Stock Math Operators Price Series Summation
| SONN Stock | USD 2.63 0.14 5.05% |
| Symbols |
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Sonnet Biotherapeutics Price Series Summation is a cross summation of Sonnet Biotherapeutics price series and its benchmark/peer.
Sonnet Biotherapeutics Technical Analysis Modules
Most technical analysis of Sonnet Biotherapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sonnet from various momentum indicators to cycle indicators. When you analyze Sonnet charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sonnet Biotherapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sonnet Biotherapeutics Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sonnet Biotherapeutics Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Sonnet Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sonnet Biotherapeutics's daily price indicators and compare them against related drivers, such as math operators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Sonnet Biotherapeutics's intrinsic value. In addition to deriving basic predictive indicators for Sonnet Biotherapeutics, we also check how macroeconomic factors affect Sonnet Biotherapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2024 (projected) | Interest Debt Per Share | 0.003788 | 29.4K | Revenue Per Share | 1.77 | 91.8K |
Learn to be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Sonnet Biotherapeutics pair trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sonnet Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Sonnet Biotherapeutics Pair Trading
Sonnet Biotherapeutics Holdings Pair Trading Analysis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 0.019 | Quarterly Revenue Growth (0.50) | Return On Assets (0.97) | Return On Equity (2.65) |
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.